# Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya

> **NCT03342027** · PHASE3 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 300 (actual)

## Conditions studied

- HIV
- Smoking Cessation

## Interventions

- **DRUG:** Bupropion
- **BEHAVIORAL:** Positively smoke free
- **OTHER:** Brief advice to quit smoking

## Key facts

- **NCT ID:** NCT03342027
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2023-07-25
- **Final completion:** 2023-07-25
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2025-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03342027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03342027, "Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03342027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*